20,800 more Sinovac vaccines arrive in Metro Cebu

By: Delta Dyrecka Letigio - CDN Digital Multi-Media Reporter | June 23,2021 - 02:38 PM

AFP STOCK PHOTO

CEBU CITY, Philippines — The Department of Health in Central Visayas (DOH-7) has received 20,800 more doses of the Sinovac vaccine on Wednesday, June 23, 2021, from the national government.

DOH-7 said in a text message to the media that the vaccines will be distributed in Metro Cebu alone.

Doctor Van Baton, spokesperson of the DOH-7 said that ahead of the others, 5,000 doses are allocated to Cebu City while 4,000 are allocated to Talisay City.

“We received 20,800 doses of Sinovac. This will be allocated for Metro Cebu. We have delivered initially 5,000 doses to Cebu City and 4,000 doses to Talisay City. The allocation of the remaining doses will be finalized today. These vaccines can be used for A4,” said Baton.

The vaccines have been delivered to the respective cities already allowing the two cities to continue their roll-out soon.

The vaccines can already be used for the A4 priority group or for workers, which would be the first for the local government units (LGUs) since the start of the vaccination roll-out.

With the arrival of the vaccines, the Cebu City government recently announced the resumption of its roll-out of the vaccines.

Doctor Jeffrey Ibones said in a text message that they will be meeting today to discuss which sites will open first. It is not yet clear if they will be prioritizing the A4.    /rcg

Subscribe to our regional newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: A4 priority group, Cebu City, COVID-19, COVID-19 vaccination, DOH-7, Mdtro Cebu, Sinovac vaccines, Talisay City

Subscribe to our regional newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.